Kretzchmar HA , DeArmond SJ, Koch TK: Pyruvate dehydrogenase complex deficiency as the etiology of Leigh disease. Pediatrics1986;79:370-373.
2.
DiMauro S., Seridei S., Zeviani M.: Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol1987;22:499-505.
3.
Ciafaloni E. , Santorelli FM, Shanske S., et al: Maternally inherited Leigh syndrome . J Pediatr1993;122:419-422.
4.
Tatuch Y., Christodoulou J., Feigenbaum A., et al: Heteroplasmic mtDNA mutation (T → G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet1992;50:852-858.
5.
deVires DD, Van Engelen Bgm, Gabreels Fjm, et al: A second missence mutation in the mitochondrial ATPase 6 gene in Leigh syndrome. Ann Neurol1993;34:410-412.
6.
Santorelli FM , Shanske S., Jain KD, et al: A T → C mutation at nt8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology1994;44:972-974.
7.
Santorelli FM , Mak SC, Vazequez-Memije ME, et al: Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res1996;39:914-917.
8.
Tatuch Y., Robinson BH: The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun1993;92:124-128.
9.
Vazquez-Memije ME, Shanske S., Santorelli FM, et al: Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherited Metab Dis1996;19:43-50.